Biotherapeutics
Editat de Lyn H Jones, Andrew J McKnighten Limba Engleză Hardback – 17 sep 2013
Preț: 1313.39 lei
Preț vechi: 1382.52 lei
-5%
Puncte Express: 1970
Preț estimativ în valută:
232.27€ • 272.57$ • 201.46£
232.27€ • 272.57$ • 201.46£
Carte tipărită la comandă
Livrare economică 09-23 martie
Specificații
ISBN-13: 9781849736015
ISBN-10: 1849736014
Pagini: 330
Ilustrații: illustrations
Dimensiuni: 163 x 239 x 24 mm
Greutate: 0.67 kg
Editura: RSC Publishing
ISBN-10: 1849736014
Pagini: 330
Ilustrații: illustrations
Dimensiuni: 163 x 239 x 24 mm
Greutate: 0.67 kg
Editura: RSC Publishing
Cuprins
Synthetic Vaccines; Peptide Epitope Expressions; Carbohydrate vaccines; MicroRNA; Recent Advances in Antibody-Directed Conjugates; Selective Protein Modifications; Immunopharmacotherapy; Technologies being applied to B cell repertoire screening for Antibodies against Infectious Pathogens; Cyclotides and Cysteine-Knot Peptides; Phage Expression of Chemically-Constrained Cyclic Peptides; Nanobodies
Textul de pe ultima copertă
This book will illustrate the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text will highlight recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches.
Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding.
Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia.
Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding.
Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book will provide essential reading for medicinal and pharmaceutical chemists working in both industry and academia.